Greene Barry E - President and CEO, Director at Sage Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
SAGE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Greene Barry E since 12/17/2023

Holdings reported by Greene Barry E for Sage Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 85.1K $762K $8.96 Aug 5, 2024 Direct
Stock Option (Right to Buy) 168K Feb 13, 2024 Direct Common Stock

Transactions reported by Greene Barry E for Sage Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.